Applications of 1-(2-Piperidinoethyl)Piperazine in Industrial Manufacturing

As a direct manufacturer of 1-(2-Piperidinoethyl)Piperazine, we supply this specialty amine to a select range of industries that rely on high-purity intermediates for critical downstream synthesis. The compound plays a specialized role in several established sectors, where application parameters, quality standards, and process integration demand strict manufacturing control. Below, we outline major industrial uses supported by regulatory compliance, application-specific formulation guidance, detailed process steps, and typical end products delivered by leading industry customers.

1. Pharmaceutical Intermediate for Antipsychotic Drug Synthesis

In pharmaceutical manufacturing, 1-(2-Piperidinoethyl)Piperazine serves as an essential intermediate during the multi-step synthesis of certain atypical antipsychotic active pharmaceutical ingredients (APIs), especially those based on piperazine core structures. Its role at the penultimate reaction stage requires strict analytical monitoring and trace impurity control to meet API precursor quality, while batch-to-batch consistency is crucial for downstream GMP certification.

Industry compliance standards

• ICH Q7: Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients
• Current Good Manufacturing Practice (cGMP) per US FDA 21 CFR Part 210/211
• European Pharmacopoeia (Ph. Eur.) monographs for relevant APIs
• Certificate of Suitability (CEP) for controlled intermediates under EDQM oversight

Typical usage ratio

• Employed at 0.8–1.1 molar equivalents relative to the API core scaffold, adjusted depending on targeted reaction yield and impurity profile; use at 96–99% purity required for downstream crystallization efficiency.

Downstream process integration

• Introduced during the key coupling or cyclization step, typically after initial halogenation or activation of the parent structure, followed by HPLC-controlled purification for final API salt formation.

Final product types

• Bulk APIs for atypical antipsychotic medications (e.g., aripiprazole analogs)
• GMP-regulated pharmaceutical intermediates for global formulation houses
• Research compounds for CNS drug development programs

2. Building Block for Specialty Agrochemical Synthesis

Agrochemical manufacturers use 1-(2-Piperidinoethyl)Piperazine as a highly functionalized building block in the production of selective herbicides and some systemic fungicides. Its nitrogen-rich backbone allows for downstream functionalization via alkylation and acylation, supporting the creation of molecules with increased selectivity towards target plant or fungal species. Production strictly adheres to environmental and operator safety standards for crop science intermediates.

Industry compliance standards

• FAO/WHO: Specifications and Codes of Practice for pesticide active ingredients
• REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) compliance for agro-intermediates in Europe
• ISO 9001:2015 for quality management during synthesis and QC release
• National Chemical Inventory Registration (e.g., TSCA for US, IECSC for China)

Typical usage ratio

• Generally incorporated at 1.0–1.3 molar equivalents in target herbicide syntheses, with ratios optimized based on post-reaction workup and yield in pilot plant trials; purity selection (95–98%) balances cost-efficiency in bulk agricultural production.

Downstream process integration

• Feeds in at the nucleophilic substitution or condensation stage, often followed by aqueous extraction and sequential derivatization prior to salt formation and granulation for field application formulations.

Final product types

• Concentrated herbicide intermediates for proprietary crop protection chemistries
• Active ingredient precursors for systemic seed-treatment fungicides
• Custom agrochemical actives for contract synthesis partners

3. Intermediate in Polymeric Flocculant Production for Water Treatment

Producers of water treatment chemicals integrate our product as a key monomer modifier during the synthesis of advanced cationic polymeric flocculants designed for industrial and municipal water clarification. The compound’s secondary amine groups contribute to polymer chain branching and charge density, enhancing pollutant aggregation performance to meet regulatory discharge limits.

Industry compliance standards

• NSF/ANSI/CAN 60: Drinking Water Treatment Chemicals—Health Effects
• ISO 14001:2015 Environmental Management for chemical plants
• REACH registration for use in water treatment polymers (Europe)
• US EPA Guidelines for Water Additive Components

Typical usage ratio

• Added at 5–15 weight percent of total monomer mass in the copolymerization process. The actual content is optimized based on desired molecular weight and solution viscosity required by end-users.

Downstream process integration

• Introduced directly into aqueous or solvent-based polymerization reactors as a co-monomer, with subsequent crosslinking and post-polymerization neutralization tailored for sedimentation or filtration aid properties.

Final product types

• Cationic polyacrylamide flocculants for high-load wastewater clarification
• Specialty coagulants for mining, oil & gas produced water treatment
• Sludge thickening agents for municipal sewage facilities

4. Synthesis Aid for CNS Active Compound Libraries (Fine Chemicals)

In the custom synthesis of CNS-focused research molecules, medicinal chemistry labs value 1-(2-Piperidinoethyl)Piperazine as a flexible precursor for rapid analog development. Its use supports the creation of compound libraries for structure-activity relationship (SAR) studies. Research-scale processes depend on analytical traceability and compliance with laboratory standards for handling hazardous substances.

Industry compliance standards

• OECD GLP Principles for non-clinical laboratory research
• ISO/IEC 17025 accreditation for analytical validation of synthesized compounds
• NIH Chemical Safety and control policies for custom molecule supply
• Internal corporate guidelines on controlled substance intermediates

Typical usage ratio

• Deployed at 0.5–2.0 molar equivalents, dosage tailored according to the synthetic target’s ring closure or side-chain substitution requirements; selection of 98%+ purity for lead compound preparation.

Downstream process integration

• Employed as the N-heterocyclic nucleophile in parallel library synthesis, typically upstream of Boc-deprotection or urea/thiourea coupling schemes, with subsequent chromatographic isolation for SAR paneling.

Final product types

• CNS drug candidate libraries for pre-clinical screening
• Custom reference standards for pharmaceutical R&D groups
• Tool compounds for in vitro or in vivo pharmacology assays